Oncology Clinical Trials in Westwood, KS

As of June 2026, 84 paid clinical trials are recruiting for Oncology in Westwood, Kansas. Oncology trials evaluate immunotherapies, targeted therapies, antibody-drug conjugates, and combination regimens across solid tumors and blood cancers — from early-phase first-in-human studies to phase 3 registration trials. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: June 12, 2026.

Filter results

Filter results

State

City

Facility

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

84 clinical trials for Oncology

·Clear filters·↓ Download CSV

A Long-term Extension Study of PCI-32765 (Ibrutinib)

for Chronic Lymphocytic Leukemia

Drug: Ibrutinib

32 locations incl. Duarte

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT01804686·Phase 3·Recruiting

Apply to this trial

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

for Hematologic Malignancies

142 locations incl. Birmingham

Sponsor: Center for International Blood and Marrow Transplant Research

Sex: All·Age: All ages

Code: NCT01351545·Recruiting

Apply to this trial

Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry

for Breast Cancer

11 locations incl. Hays

Sponsor: University of Kansas Medical Center

Sex: All·Age: All ages·Accepts healthy volunteers

Code: NCT02302742·Recruiting

Apply to this trial

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

for Breast Neoplasms

42 locations incl. Birmingham

Sponsor: QuantumLeap Healthcare Collaborative

Sex: All·Age: 18+

Code: NCT01042379·Phase 2·Recruiting

Apply to this trial

Conditions in Oncology (Westwood, KS)

Solid tumor· 11 Breast cancer· 10 Non-small cell lung cancer (NSCLC)· 10 Acute myeloid leukemia (AML)· 8 Multiple myeloma· 6 Non-Hodgkin lymphoma· 6 Colorectal cancer· 4 Chronic lymphocytic leukemia (CLL)· 4 Diffuse large B-cell lymphoma (DLBCL)· 4 Mantle cell lymphoma· 4 Hematologic malignancy· 4 Pancreatic cancer· 3 Gastric cancer· 3 Liver cancer· 3 Prostate cancer· 3 Metastatic prostate cancer· 3 Ovarian cancer· 3 Endometrial cancer· 3 Myelodysplastic syndromes (MDS)· 3 Myelofibrosis· 3 Follicular lymphoma· 3 Small lymphocytic lymphoma· 3 Melanoma· 3 Cancer (any)· 3 Metastatic breast cancer· 2 Triple-negative breast cancer· 2 Esophageal cancer· 2 Fallopian tube cancer· 2 Hodgkin lymphoma· 2 Head and neck cancer· 2 HER2-positive breast cancer· 1 HER2-negative breast cancer· 1 Gastroesophageal junction cancer· 1 Biliary tract cancer· 1 Gastrointestinal cancer· 1 Uterine cancer· 1 Acute lymphoblastic leukemia· 1 Marginal zone lymphoma· 1 Mesothelioma· 1